Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Sorrento Therapeutics Inc Stock Halal?
Shariah Compliance Analysis of SRNE Stock
United States Health Care Nano Cap Yes. As of November 2026, Sorrento Therapeutics Inc (SRNE) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Sorrento Therapeutics Inc passes Musaffa's business and financial screening criteria.
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is headquartered in San Diego, California and currently employs 949 full-time employees. The company went IPO on 2007-01-19. The firm is engaged in developing a portfolio of next-generation treatments for cancer, infectious diseases and pain. The company is also developing Resiniferatoxin (RTX), a naturally occurring non-opioid ultra-potent transient receptor potential vanilloid-1 agonist. The Company’s proprietary fully human G-MAB antibody library and ACEA small molecule library are the pipeline of new solutions for cancer. Its diagnostics platforms include the COVIMARK lateral flow antigen test and the VIREX platform.
SRNE Shariah Compliance
Screening Methodology: AAOIFI
As of November 2026, Sorrento Therapeutics Inc is classified as halal.
HALALSorrento Therapeutics Inc (SRNE) Chart
Fetching Price Chart...
Financial Metrics & Statements of Sorrento Therapeutics Inc (SRNE)
FAQ's for Sorrento Therapeutics Inc (SRNE)
- As of November 2026, Sorrento Therapeutics Inc SRNE is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sorrento Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Sorrento Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Sorrento Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Sorrento Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Sorrento Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Sorrento Therapeutics Inc (SRNE)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
